


Bio Protocol is currently trading at approximately $0.03145 per token, reflecting notable downward pressure in the digital asset market. The token has experienced a significant 24-hour decline, with price movements ranging between a low of $0.02911 and a high of $0.03275 during this period. This trading activity underscores the volatility characteristic of decentralized science tokens, particularly as BIO continues to establish itself within the cryptocurrency landscape.
The market cap for Bio Protocol stands at approximately $60.25 million based on circulating supply, with a fully diluted valuation reaching around $101 million. This valuation reflects the token's position among mid-tier cryptocurrency assets and demonstrates substantial investor participation. The trading volume within the last 24 hours exceeded $23 million, indicating active market engagement despite the price decline.
This current price level represents a pullback from earlier positions, yet maintains support above critical psychological levels. Traders monitoring BIO Protocol's performance should note that the 24-hour trading metrics reveal both liquidity and interest from market participants. The combination of current pricing, market capitalization, and trading volume provides valuable context for understanding Bio Protocol's market dynamics and investor sentiment during this period.
The $26.7 million 24-hour trading volume for Bio Protocol demonstrates substantial market participation and robust liquidity conditions across exchange platforms. This significant trading activity reflects genuine investor interest in the BIO token and indicates a healthy market capable of absorbing both buy and sell orders without extreme price slippage. Trading volume serves as a critical indicator of market depth, showing that participants can execute trades at competitive prices during peak activity periods.
Market liquidity, directly influenced by trading volume, enables traders to move in and out of positions more efficiently. When 24-hour trading volume remains consistently elevated, it suggests the Bio Protocol ecosystem maintains strong accessibility for market participants. The volume data across multiple exchanges demonstrates that BIO tokens circulate actively within the crypto trading community, reducing friction for those seeking exposure to decentralized science protocols. This liquidity foundation supports both institutional and retail traders, contributing to price stability and reducing the risk of extreme volatility. For investors evaluating Bio Protocol as part of their cryptocurrency portfolio, understanding this trading activity provides reassurance about market maturity and the ability to execute their trading strategies effectively.
BIO's market distribution reveals a structured token ecosystem with significant liquidity infrastructure. The circulating supply of approximately 1.98 billion tokens represents roughly 60% of the total supply cap of 3.32 billion, indicating a substantial portion of tokens remain locked or unvested. This supply structure influences price dynamics and market availability across platforms.
Exchange coverage demonstrates BIO's robust market presence, with listings spanning 60+ platforms offering 75 distinct trading pairs. This extensive exchange coverage ensures multiple entry and exit points for traders, with major platforms providing both spot and futures trading opportunities. The distribution across such diverse trading venues enhances market accessibility while reducing single-exchange dependency risk.
The circulating supply metrics directly impact liquidity conditions on individual exchanges. Higher circulating supply availability, combined with widespread exchange distribution, facilitates deeper order books and tighter spreads across gate and other major trading venues. This market distribution model supports consistent trading volume and price discovery mechanisms, essential characteristics for an emerging decentralized science protocol gaining institutional and retail adoption across global cryptocurrency markets.
Bio Protocol (BIO) is a cryptocurrency token designed for decentralized bioinformatics and life science data exchange. It enables users to trade, stake, and participate in governance within the BIO ecosystem. Primary applications include incentivizing data contribution, facilitating peer-to-peer transactions, and supporting research collaboration networks in the biotech sector.
BIO token is currently priced at $0.032701 with a market cap of $64.63M. The 24-hour trading volume is $27.68M.
BIO tokens can be purchased and traded on major cryptocurrency exchanges. Register an account, complete identity verification, and then trade BIO through spot or futures markets. Check official channels for current exchange listings and trading pairs.
Bio Protocol's price was US$0.03193 on February 4, 2026, declining 1.01% in 24 hours and 29.26% over the past week. A major price drop occurred in late 2021 when it fell below US$0.10, marking a significant historical downturn for the token.
BIO token has a total supply of 3.32 billion. Initial circulating supply is approximately 1.3 billion, accounting for 39.05% of total supply. The token demonstrates relatively high scarcity characteristics.
BIO token investments carry risks including token concentration and sustainability concerns. Conduct thorough project research before investing. Evaluate tokenomics, team background, and market conditions carefully.
Bio Protocol combines capital efficiency, flexible expert contributions, and decentralized IP ownership. It reduces innovation costs through resource pooling, enables part-time expert participation, and democratizes intellectual property governance unlike traditional biotech models.
BIO tokens play a critical role in the BIO Protocol decentralized science platform. With strong backing from Binance Labs and expansion across Ethereum, Solana, and Base networks, BIO is positioned for significant growth as the DeSci sector matures. The protocol aims to expand its BioDAO network and deepen liquidity markets for scientific IP, with promising long-term value potential in the rapidly growing biotechnology industry.











